title: The transfection activity of R8-modified nanoparticles and siRNA condensation using pH sensitive stearylated-octahistidine.
abstract: Emerging evidence indicates that the efficiency of siRNA loading into an RNA-induced silencing complex (RISC) is a major factor in gene silencing at low doses. In particular, the release of siRNA from components delivered to the cytoplasm could be a first step for achieving maximum gene knockdown effect in siRNA delivery vector. To test this hypothesis, we used a stearylated-octahistidine (STR-H8) as a pH responsive polycation that facilitates the efficient release of siRNA into the cytoplasm, while a stearylated-octaarginine (STR-R8) was used as a conventional cationic polycation. As a fundamental structure, we used octaarginine (R8) and GALA, as a pH-sensitive fusogenic peptide, modified lipid envelope-type nanoparticles (R8/GALA-MEND(SUV)), as reported previously. When STR-H8/siRNA condensed complexes were loaded in the R8/GALA-MEND(SUV), the luciferase knockdown effect was significantly increased compared to STR-R8/siRNA condensed complexes in time and dose dependent manners. Quantification of the released siRNA from the condensed complexes demonstrated that only the STR-H8/siRNA released significant levels of siRNA at pH = 7.4, the pH of cytoplasmic, compared with STR-R8/siRNA condensed complexes. In addition, imaging studies indicated that STR-H8/siRNA facilitated siRNA release. Collectively, these data reveal the importance of the controlled release of siRNA to the cytoplasm.
authors.affiliation: Faculty of Pharmaceutical Sciences, Hokkaido University, Hokkaido, Japan.
authors.forename: Naoyuki
authors.initials: N
authors.lastname: Toriyabe
authors.forename: Yasuhiro
authors.initials: Y
authors.lastname: Hayashi
authors.forename: Hideyoshi
authors.initials: H
authors.lastname: Harashima
mesh_terms: D006639:Histidine / Q000737:chemistry*; D006863:Hydrogen-Ion Concentration; D053769:Nanocapsules / Q000008:administration & dosage* / Q000737:chemistry*; D009842:Oligopeptides / Q000737:chemistry*; D034741:RNA, Small Interfering / Q000008:administration & dosage* / Q000235:genetics*; D014162:Transfection / Q000379:methods*
chemical_list: D053769:Nanocapsules; D009842:Oligopeptides; D034741:RNA, Small Interfering; C500307:octa-arginine peptide; D006639:Histidine